Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
VMF
0
FDF
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
1. Jatrosom
2. Parnate
3. Sulfate, Tranylcypromine
4. Trans 2 Phenylcyclopropylamine
5. Trans-2-phenylcyclopropylamine
6. Transamine
7. Tranylcypromine
8. Tranylcypromine Sulfate
1. Tranylcypromine Sulfate
2. 13492-01-8
3. Tranylcypromine Sulfate (usp)
4. Chebi:9653
5. D00826
Molecular Weight | 364.5 g/mol |
---|---|
Molecular Formula | C18H24N2O4S |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 2 |
Exact Mass | 364.14567842 g/mol |
Monoisotopic Mass | 364.14567842 g/mol |
Topological Polar Surface Area | 135 Ų |
Heavy Atom Count | 25 |
Formal Charge | 0 |
Complexity | 197 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 2 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
Anti-Anxiety Agents
Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here. (See all compounds classified as Anti-Anxiety Agents.)
Antidepressive Agents
Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems. (See all compounds classified as Antidepressive Agents.)
Monoamine Oxidase Inhibitors
A chemically heterogeneous group of drugs that have in common the ability to block oxidative deamination of naturally occurring monoamines. (From Gilman, et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p414) (See all compounds classified as Monoamine Oxidase Inhibitors.)
Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.
GDUFA
DMF Review : Reviewed
Rev. Date : 2014-06-18
Pay. Date : 2013-02-08
DMF Number : 26808
Submission : 2013-02-18
Status : Active
Type : II
NDC Package Code : 58159-082
Start Marketing Date : 2021-06-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (35kg/35kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2019-05-17
Pay. Date : 2019-05-13
DMF Number : 16522
Submission : 2003-02-27
Status : Active
Type : II
NDC Package Code : 46204-0130
Start Marketing Date : 2017-12-27
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 10317
Submission : 1993-06-25
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 716
Submission : 1963-11-04
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 4680
Submission : 1982-10-28
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 7132
Submission : 1987-09-04
Status : Inactive
Type : II
NDC Package Code : 46204-0130
Start Marketing Date : 2017-12-27
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Date of Issue : 2022-06-08
Valid Till : 2025-06-25
Written Confirmation Number : WC-0107
Address of the Firm :
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
RLD : No
TE Code : AB
Brand Name : TRANYLCYPROMINE SULFATE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 10MG BASE
Approval Date : 2006-06-29
Application Number : 40640
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : Yes
TE Code : AB
Brand Name : PARNATE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 10MG BASE
Approval Date : 1985-08-16
Application Number : 12342
RX/OTC/DISCN : RX
RLD : Yes
TE Code : AB
RLD : No
TE Code : AB
Brand Name : TRANYLCYPROMINE SULFATE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 10MG BASE
Approval Date : 2018-04-17
Application Number : 206856
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
Brand Name : TRANYLCYPROMINE SULFATE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 10MG BASE
Approval Date : 2022-06-27
Application Number : 213503
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Italy
Tranylcypromine; Trifluoperazine
Brand Name : Parmodalin
Dosage Form :
Dosage Strength : 25 Cpr Riv 10 Mg + 1 Mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info : Prescription
Registration Country : Canada
TRANYLCYPROMINE (TRANYLCYPROMINE SULFATE)
Brand Name : PARNATE
Dosage Form : TABLET
Dosage Strength : 10MG
Packaging : 100
Approval Date :
Application Number : 1919598
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info :
Registration Country : Australia
Brand Name : Parnate
Dosage Form : tablet
Dosage Strength : 10 mg
Packaging : 50
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Parnate
Dosage Form : TAB
Dosage Strength : 10mg
Packaging : 28X1mg
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Tablet
Dosage Strength : 10MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging :
Regulatory Info :
Dosage : Tablet
Dosage Strength : 10MG
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Regulatory Info :
Registration Country : Spain
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 10MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Spain
Packaging :
Regulatory Info :
Dosage : Film Coated Tablet
Dosage Strength : 10MG
Brand Name :
Approval Date :
Application Number :
Registration Country : Spain
Regulatory Info :
Registration Country : Spain
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 20MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Spain
Packaging :
Regulatory Info :
Dosage : Film Coated Tablet
Dosage Strength : 20MG
Brand Name :
Approval Date :
Application Number :
Registration Country : Spain
Regulatory Info :
Registration Country : Spain
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 40MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Spain
Packaging :
Regulatory Info :
Dosage : Film Coated Tablet
Dosage Strength : 40MG
Brand Name :
Approval Date :
Application Number :
Registration Country : Spain
Related Excipient Companies
Dosage Form : Tablet
Grade : Not Available
Brand Name : Kollicoat Protect
Application : Coating Systems & Additives
Excipient Details : Flexible water soluble instant release coating polymer, especially used for moisture protection
Pharmacopoeia Ref : Excipient based on Kollicoat®...
Technical Specs : Not Available
Ingredient(s) : Polyvinyl Alcohol Graft Polyethylene Glycol Copolymer
Dosage Form : Granule / Pellet
Grade : Not Available
Application : Direct Compression
Excipient Details : Ready-to-use direct compression solution for tablets.
Dosage Form : Granule / Pellet
Grade : Not Available
Application : Direct Compression
Excipient Details : Ready-to-use direct compression solution for lozenges, chewables and effervescent tablets.
Pharmacopoeia Ref : Ph. Eur., USP/NF and J.P
Technical Specs : Not Available
Ingredient(s) : Lactose
Excipients by Applications
20 Apr 2018
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206856
02 Apr 2018
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/duchesnay-usa-announces-launch-of-bonjesta-doxylamine-succinate---pyridoxine-hydrochloride-in-the-united-states-300620521.html
Global Sales Information
Company :
Tranylcypromine Sulfate
Drug Cost (USD) : 606,886
Year : 2022
Prescribers : 47
Prescriptions : 300
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company :
Tranylcypromine Sulfate
Drug Cost (USD) : 4,306,974
Year : 2022
Prescribers : 1803
Prescriptions : 11120
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company :
Tranylcypromine Sulfate
Drug Cost (USD) : 641,622
Year : 2021
Prescribers : 48
Prescriptions : 341
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company :
Tranylcypromine Sulfate
Drug Cost (USD) : 4,333,196
Year : 2021
Prescribers : 1857
Prescriptions : 11869
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company :
Tranylcypromine Sulfate
Drug Cost (USD) : 667,545
Year : 2020
Prescribers : 60
Prescriptions : 427
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company :
Tranylcypromine Sulfate
Drug Cost (USD) : 4,747,205
Year : 2020
Prescribers : 1896
Prescriptions : 12346
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company :
Tranylcypromine Sulfate
Drug Cost (USD) : 725,688
Year : 2019
Prescribers : 76
Prescriptions : 506
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company :
Tranylcypromine Sulfate
Drug Cost (USD) : 5,323,623
Year : 2019
Prescribers : 1891
Prescriptions : 12667
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company :
Tranylcypromine Sulfate
Drug Cost (USD) : 832,918
Year : 2018
Prescribers : 94
Prescriptions : 577
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company :
Tranylcypromine Sulfate
Drug Cost (USD) : 5,202,313
Year : 2018
Prescribers : 1997
Prescriptions : 13375
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
RX/OTC/DISCN : RX
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 10MG BASE
Price Per Pack :
Published in :
Country : USA
RX/OTC/DISCN : RX
SIT LABORATORIO FARMAC. Srl
Tranylcypromine Sulfate; Trifluoperazine
Dosage Form :
Dosage Strength : 25 Cpr Riv 10 Mg + 1 Mg
Price Per Pack (Euro) : 8.87
Published in :
Country : Italy
RX/OTC/DISCN : Class C
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?